HomeCompareEUCR vs SCHD

EUCR vs SCHD: Dividend Comparison 2026

EUCR yields 19.92% · SCHD yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EUCR wins by $43.7K in total portfolio value
10 years
EUCR
EUCR
● Live price
19.92%
Share price
$10.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.7K
Annual income
$6,681.84
Full EUCR calculator →
SCHD
Schwab U.S. Dividend Equity ETF
● Live price
3.44%
Share price
$30.68
Annual div
$1.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$422.61
Full SCHD calculator →

Portfolio growth — EUCR vs SCHD

📍 EUCR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEUCRSCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EUCR + SCHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EUCR pays
SCHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EUCR
Annual income on $10K today (after 15% tax)
$1,693.23/yr
After 10yr DRIP, annual income (after tax)
$5,679.56/yr
SCHD
Annual income on $10K today (after 15% tax)
$292.49/yr
After 10yr DRIP, annual income (after tax)
$359.22/yr
At 15% tax rate, EUCR beats the other by $5,320.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EUCR + SCHD for your $10,000?

EUCR: 50%SCHD: 50%
100% SCHD50/50100% EUCR
Portfolio after 10yr
$50.8K
Annual income
$3,552.22/yr
Blended yield
6.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EUCR buys
0
SCHD buys
0
No recent congressional trades found for EUCR or SCHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEUCRSCHD
Forward yield19.92%3.44%
Annual dividend / share$2.00$1.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$72.7K$29.0K
Annual income after 10y$6,681.84$422.61
Total dividends collected$41.2K$3.9K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: EUCR vs SCHD ($10,000, DRIP)

YearEUCR PortfolioEUCR Income/yrSCHD PortfolioSCHD Income/yrGap
1← crossover$12,692$1,992.03$11,224$344.10+$1.5KEUCR
2$15,943$2,362.89$12,567$354.98+$3.4KEUCR
3$19,833$2,774.01$14,038$365.30+$5.8KEUCR
4$24,447$3,225.09$15,648$375.06+$8.8KEUCR
5$29,873$3,715.22$17,410$384.27+$12.5KEUCR
6$36,207$4,242.88$19,335$392.95+$16.9KEUCR
7$43,548$4,806.07$21,437$401.10+$22.1KEUCR
8$51,999$5,402.29$23,733$408.75+$28.3KEUCR
9$61,667$6,028.62$26,237$415.91+$35.4KEUCR
10$72,666$6,681.84$28,968$422.61+$43.7KEUCR

EUCR vs SCHD: Complete Analysis 2026

EUCRStock

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Full EUCR Calculator →

SCHDETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →
📬

Get this EUCR vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EUCR vs JEPIEUCR vs OEUCR vs KOEUCR vs MAINEUCR vs VYMEUCR vs DGROEUCR vs VIGEUCR vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.